ASX 200 (INDEXASX:XJO) share prices follows US lower
Drew Meredith, CFP
April 12, 2024
A 3.8 per cent US inflation print contributed to a
AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.
A 3.8 per cent US inflation print contributed to a
Jeremy Curnock Cook of BioScience Managers and Dr Megan Baldwin
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed
The S&P/ASX 200 (ASX:XJO) finished at another record on Wednesday.
The AVITA Medical Inc (ASX:AVH) share price is soaring today,
The AVITA Medical Inc (ASX:AVH) share price is up more
This morning, medical device developer Avita Medical Inc (ASX: AVH)
Avita Medical Inc (ASX: AVH) reports positive numbers in its
The Avita Therapeutics Inc (ASX: AVH) share price was trading
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
